Comapring Luteal Phase Support in IVF Patients Who Are at High Risk for Developing OHSS

• Status: Unknown status
• Trial end date: 2017-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to compare two luteal support protocols in In vitro fertilization patients (IVF) and are at risk of developing ovarian hyperstimulation syndrome (OHSS). We would like to determine whether luteal Decapeptyl on days 3, 6,9 post ovulation triggering is as good as low dose hCG on day 3 post triggering..

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Meir Medical Center
• Treatments: Chorionic Gonadotropin; Triptorelin Pamoate

Criteria

Inclusion Criteria:

• IVF treatment

• GnRH antagonist protocol

• GnRH agonist triggering of ovulation

• High risk for OHSS as expressed by either E2 serum level >2500 pg/ml

Exclusion Criteria:

• background maternal morbidity

• Any protocol other than GnRH antagonist protocol

• hCG triggering of ovulation

• E2 serum level >4500 pg/ml

• Aspiration of >25 ova

• Embryo transfer prior to day 5